Purple Biotech (PPBT) Enterprise Value (2014 - 2026)
Purple Biotech (PPBT) reported Enterprise Value of -$6.5 million for Q1 2026, up 12.35% year-over-year from -$5.8 million in Q1 2025, and up 32.66% on a QoQ basis from -$9.6 million in Q4 2025.
Purple Biotech (PPBT) has 11 years of Enterprise Value data on file, last reported at -$6.5 million in Q1 2026.
- Quarterly Enterprise Value rose 12.35% year-over-year to -$6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.5 million (up 12.35% YoY) and the FY2025 annual result came in at -$9.6 million, down 25.44% from the prior year.
- Enterprise Value climbed to -$6.5 million in Q1 2026 per PPBT's latest filing, from -$9.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$6.5 million in Q1 2026 and bottomed at -$15.5 million in Q4 2022.
- The 5-year median for Enterprise Value is -$8.7 million (2024), against an average of -$10.2 million.
- The widest annual swing landed in 2022, when Enterprise Value soared 67.24%; it then fell 25.44% in 2025.
- Tracing PPBT's Enterprise Value over 5 years: stood at -$15.5 million in 2022, then increased by 5.81% to -$14.6 million in 2023, then jumped by 47.29% to -$7.7 million in 2024, then decreased by 25.44% to -$9.6 million in 2025, then soared by 32.66% to -$6.5 million in 2026.
- Per Business Quant, the three latest PPBT Enterprise Value figures stand at -$6.5 million (Q1 2026), -$9.6 million (Q4 2025), and -$7.4 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | -6.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.48 Mn |
| Dec 31, 2025 | -9.57 Mn |
| Sep 30, 2025 | -8.26 Mn |
| Jun 30, 2025 | -5.59 Mn |
| Mar 31, 2025 | -8.25 Mn |
| Dec 31, 2024 | -7.68 Mn |
| Sep 30, 2024 | -6.29 Mn |
| Jun 30, 2024 | -7.37 Mn |
| Mar 31, 2024 | -10.83 Mn |
| Dec 31, 2023 | -15.34 Mn |
| Sep 30, 2023 | -15.95 Mn |
| Jun 30, 2023 | -18.05 Mn |
| Mar 31, 2023 | -22.73 Mn |
| Dec 31, 2022 | -15.27 Mn |
| Sep 30, 2022 | -33.08 Mn |
| Jun 30, 2022 | -32.90 Mn |
| Mar 31, 2022 | -39.55 Mn |
| Dec 31, 2021 | -46.92 Mn |
| Sep 30, 2021 | -47.69 Mn |
| Jun 30, 2021 | -48.39 Mn |
| Mar 31, 2021 | -55.45 Mn |
| Dec 31, 2020 | -57.44 Mn |
| Jun 30, 2020 | -63.01 Mn |
| Dec 31, 2019 | -6.39 Mn |
| Jun 30, 2019 | -7.82 Mn |
| Dec 31, 2018 | -6.68 Mn |
| Jun 30, 2018 | -11.83 Mn |
| Dec 31, 2017 | -7.44 Mn |
| Jun 30, 2017 | -14.36 Mn |
| Dec 31, 2016 | -14.66 Mn |
| Jun 30, 2016 | -15.06 Mn |
| Dec 31, 2015 | -10.70 Mn |
| Sep 30, 2015 | -981,000.00 |
| Dec 31, 2014 | -1.31 Mn |
| Sep 30, 2014 | -2.42 Mn |